Delfina Teixeira | Nursing | Young Scientist Award

Posted on by sciencefather

Assoc. Prof. Dr. Delfina Teixeira | Nursing | Young Scientist Award

Delfina Ana Pereira Ramos Teixeira is a dedicated Portuguese nursing professional and academic with extensive experience in clinical practice, teaching, and research. Currently an Adjunct Professor at both the University of Trás-os-Montes and Alto Douro and the Polytechnic Institute of Santarém, she combines her clinical expertise with academic responsibilities. Her professional journey includes roles in hospital settings, higher education institutions, and research centers, reflecting her commitment to advancing nursing education and practice. A member of prestigious organizations such as Sigma Theta Tau International, she actively contributes to curriculum development, postgraduate education, and quality assessment in nursing. Delfina is also a PhD candidate in Nursing Sciences at the University of Porto and has authored several scholarly publications focusing on mental health, clinical supervision, and family-centered care. Her career is marked by interdisciplinary collaboration, academic leadership, and a strong focus on healthcare innovation and quality improvement.

Profile

🎓 Education

Delfina Ana Pereira Ramos Teixeira holds a diverse and multidisciplinary academic background in nursing and public health administration. She is currently pursuing a PhD in Nursing Sciences at the University of Porto’s Instituto de Ciências Biomédicas Abel Salazar, focusing on advanced research in nursing education and practice. In 2023, she completed a micro-credential in Clinical Supervision from the Polytechnic Institute of Santarém, enhancing her skills in mentoring and educational leadership. She was also awarded the Specialist Title in Nursing in 2020 by the Polytechnic Institute of Bragança, in collaboration with the University of Aveiro and the School of Nursing of Coimbra, under Portuguese higher education legislation. Additionally, Delfina completed the first year of a doctoral program in Public Health Administration at the University of Lisbon in 2017. Her academic trajectory emphasizes excellence in education, clinical specialization, and healthcare system management, all of which have shaped her into a well-rounded academic and nurse leader.

🧪 Experience

Delfina Ana Pereira Ramos Teixeira brings over a decade of experience across clinical, academic, and leadership roles in nursing. Since 2023, she has served as an Adjunct Professor at the Polytechnic Institute of Santarém, and from February 2025, she holds the same role at the University of Trás-os-Montes and Alto Douro. Previously, she worked at Hospital Quiron Salud in Pontevedra, Spain, as an operating room nurse, demonstrating her strong clinical capabilities. From 2010 to 2022, she held various teaching and coordination positions at several nursing schools, including the Escola Superior de Enfermagem Cruz Vermelha Portuguesa – Alto Tâmega and Escola Superior de Enfermagem Dr. José Timóteo Montalvão Machado. Delfina has coordinated specialized post-licensure nursing courses and served on pedagogical and quality assessment councils. Her roles consistently reflect her expertise in surgical nursing, curriculum design, academic management, and clinical instruction, reinforcing her profile as an influential educator and practitioner in nursing.

🏅 Awards and Honors

Delfina Ana Pereira Ramos Teixeira has been honored through prestigious memberships, leadership appointments, and research affiliations that underscore her professional excellence. She is a member of the Phi Xi Chapter of Sigma Theta Tau International, a global honor society for nursing, since 2021—an acknowledgment of her academic distinction and leadership. Delfina is also an active researcher at the Centro de Investigação em Tecnologias e Serviços de Saúde (CINTESIS), contributing to the NursID research group focusing on nursing innovation. Between 2019 and 2022, she served in several notable roles at the Escola Superior de Enfermagem Cruz Vermelha Portuguesa – Alto Tâmega, including Vice-President of the Pedagogical Council and Coordinator of the Medical-Surgical Nursing specialization course. Her involvement in advisory boards, curriculum development teams, and quality assurance initiatives highlights her dedication to shaping the future of nursing education and research, earning her recognition across academic, clinical, and research domains.

🔬 Research Focus

Delfina Ana Pereira Ramos Teixeira’s research interests center on clinical education, mental health, family-centered care, nursing supervision, and healthcare quality. Her recent scholarly work includes studies on adolescent mental health, nursing students’ psychological resilience, and cultural adaptation of mental health literacy tools. She also investigates environmental health in nursing care, nutrition in patients with urinary ostomies, and maternal perspectives on neonatal care. Delfina emphasizes the integration of theoretical knowledge and practical skills, particularly in clinical settings where she supports the development of educational interventions to improve patient outcomes. She is an integrated member of CINTESIS and contributes to the NursID group, which fosters innovation in nursing development. Her work is often interdisciplinary and applied, aiming to bridge the gap between research and frontline healthcare. Her academic and research endeavors align with her broader goals of enhancing clinical supervision, advancing evidence-based nursing, and improving quality standards in health services and nursing education.

✅ Conclusion

Delfina Ana Pereira Ramos Teixeira is a distinguished nurse educator and researcher whose contributions to nursing practice, academic leadership, and health sciences research significantly enhance the quality and innovation of healthcare and education in Portugal.

Publications

  • Guia Orientador de Boas Práticas Clínicas Cuidados Centrados na Pessoa e na Família

    2025 | Translation

    SOURCE-WORK-ID:

    cv-prod-id-4510179

    CONTRIBUTORS: Sampaio, Francisco Miguel Correia; Sousa, Maria Rui; Oliveira, Ana Paula; Sequeira, Carlos; Imaginário, Cristina; Teixeira, Delfina; Milheiro, Isabel; et al

  • Levels of Hope, Stigma, Psychological Vulnerability, and Positive Mental Health: A Descriptive Study of Eighth- and Ninth-Grade Adolescents

    Healthcare
    2025-05-26 | Journal article
    DOI: 10.3390/healthcare13111257
    CONTRIBUTORS: Maria José Carvalho Nogueira; Delfina Teixeira

  • The Mental Health Literacy and Stigma Scale—Bilingual Cultural Adaptation: Validity and Reliability Pilot Study in Nursing Students

    Nursing Open
    2025-01 | Journal article
    DOI: 10.1002/nop2.70073
    CONTRIBUTORS: Maria José Nogueira; Síria Sas; Lucía Rodríguez; Andrea Carbonero; Uxía Bello; Leandro Nascimento; Susana Mendonça; Delfina Teixeira

  • ATIVIDADE FÍSICA DOS IDOSOS EM PORTUGAL E IMPACTOS NA SAÚDE: SCOPING REVIEW

    Enfermagem na linha de frente: experiências e lições aprendidas 2
    2024 | Book chapter
    DOI: 10.22533/at.ed.27324120211
    SOURCE-WORK-ID:

Mai Osman Mohamed Kadry | Biochemistry | Best Researcher Award

Posted on by sciencefather

Assist. Prof. Dr. Mai Osman Mohamed Kadry | Biochemistry | Best Researcher Award

Assist. Prof. Dr. Mai O.Kadry,National Research Center, Egypt

Dr. Mai Osman Mohamed Kadry is a distinguished biochemistry researcher at the Therapeutic Chemistry Department, National Research Centre, Egypt. With a Doctorate in Biochemistry from Cairo University (2016), her work focuses on oxidative injury, nanotoxicity, and cancer therapy. She has published extensively in high-impact journals on topics like antioxidant effects, stem cell therapies, and metabolic disorders. Dr. Kadry has also contributed to academia, teaching pharmacognosy at 6th October University. Skilled in advanced techniques like PCR, HPLC, and ELISA, she actively participates in groundbreaking nanobiotechnology research projects. Dr. Kadry is committed to advancing therapeutic strategies for critical diseases. 📚🧬

Profile

🎓 Education

Assist. Prof. Dr. Mai O. Kadry boasts a strong academic foundation in pharmaceutical sciences. She earned her Doctorate in Biochemistry from the Faculty of Pharmacy, Cairo University, in 2016, with a thesis on the “Amelioration of Nano-Sized Titanium Dioxide-Induced Oxidative Injury in Mice by Some Antioxidants.” She obtained her Master’s degree in Pharmaceutical Sciences from Helwan University in 2008, focusing on the synergistic effects of phytic and catechin on carbon tetrachloride-induced damage in rats. Dr. Kadry completed her B.Sc. in Pharmaceutical Science at Ain Shams University in 2003, graduating with honors. She also attended English language schools, enhancing her global communication skills. 🌟🔬

🧪 Experience

Assist. Prof. Dr. Mai O. Kadry has accumulated valuable experience in academia and research. She served as a pharmacognosy instructor at the Faculty of Pharmacy, 6th October University, Cairo, Egypt (2003–2004), where she effectively delivered courses on natural products and their therapeutic applications. Dr. Kadry also contributed as a staff member focused on development and quality enhancement, aligning with the standards of the National Commission for Academic Accreditation. Her dedication to education and quality assurance reflects her commitment to fostering academic excellence and professional growth in pharmaceutical sciences. 📚🔬

Training 🧬📚

Assist. Prof. Dr. Mai O. Kadry has undergone extensive training in various scientific disciplines. She completed courses in Biostatistics (November 2016) and Bioinformatics (January 2017) at the National Research Centre. Earlier, she gained expertise in Scientific Typewriting Bases (March 2007) and Occupational Health and Safety (June 2009). Additionally, she mastered Protein Electrophoresis through a four-month course in 2006. Dr. Kadry enhanced her practical skills with hands-on training at Al-Borg Clinical Laboratory, focusing on PCR techniques for detecting HBV and HCV at the Theodor Bilharz Research Institute. Her comprehensive training equips her with valuable laboratory and analytical skills. 🔬🧪

🔬 Research Focus

Assist. Prof. Dr. Mai O. Kadry focuses on cutting-edge biomedical research, emphasizing toxicity, cancer therapy, and molecular biology. Her work explores inflammatory mediators, DNA damage, and therapeutic approaches in liver, brain, and nephrotoxicity contexts. She investigates autophagy, necroptosis, and novel strategies like resveratrol nano-formulations for ovarian cancer. Dr. Kadry also studies molecular pathways in gastric and prostate cancers, including miRNA-lncRNA signaling and CRISPR-Cas9 applications. Other interests involve genetic mutations in leukemia, drug-delivery systems, and nanotechnology for breast cancer. Her contributions bridge diagnostics, therapeutic innovations, and cellular mechanisms in oncology and toxicology. 🔬✨

✅ Conclusion

Assist. Prof. Dr. Mai O. Kadry is a distinguished biochemistry researcher whose work bridges advanced molecular biology and therapeutic innovation. With expertise in nanotoxicity, oxidative injury, and cancer therapy, she contributes significantly to biomedical science through impactful research and academic leadership. Her training in cutting-edge techniques and her focus on translational medicine position her at the forefront of scientific discovery. Dr. Kadry’s dedication to improving healthcare through targeted therapies and her commitment to academic excellence make her a valuable asset to the scientific community. Her career reflects passion, innovation, and a relentless pursuit of better treatment solutions.

 

Publications

  • Collaboration of Hprt/K-RAS/c-Myc mutation in the oncogenesis of T-lymphocytic leukemia: a comparative study

    Future Science OA
    2024-12-31 | Journal article
    DOI: 10.2144/fsoa-2023-0111
    CONTRIBUTORS: Mai O Kadry; Abdel-Hamid Z Abdel Hamid; Rehab M Abdel-Megeed

  • Fischer’s oligopeptide ratio in ischemic hypoxia: prophylactic amendment of sophoretin and melatonin supplementation

    Future Science OA
    2024-12-31 | Journal article
    DOI: 10.2144/fsoa-2023-0117
    CONTRIBUTORS: Mai O Kadry; Hanaa Mahmoud Al

  • Thioctic acid shield against lipopolysaccharide depression and endoplasmic reticulum stress: GR7M/Homer/ATF6 signaling

    Future Science OA
    2024-12-31 | Journal article
    DOI: 10.1080/20565623.2024.2422791
    CONTRIBUTORS: Mai O. Kadry; Rehab M. Abdel-Megee

Cheng Cheng | Emotion and Cognition | Best Researcher Award

Posted on by sciencefather

Assist. Prof. Dr. Cheng Cheng | Emotion and Cognition | Best Researcher Award

Dr. Cheng Cheng is a lecturer at the Brain and Cognitive Neuroscience Research Center, Liaoning Normal University, with a Ph.D. in Computer Science from Dalian University of Technology (2024). Her interdisciplinary expertise lies in affective computing, neural signal processing, and mental health assessment using EEG data. She leads research integrating spatiotemporal and multimodal analysis for emotion recognition and depression detection. Dr. Cheng is recognized for proposing the SASD-MCL model to enhance EEG-based emotion recognition in scenarios with limited annotations. Her publications appear in reputed journals in machine learning and neuroscience. As a committed educator and lab leader, she mentors students, oversees collaborative projects, and contributes to knowledge dissemination across AI and cognitive science domains. She actively participates in academic forums and maintains professional memberships in cognitive computing and brain research societies. Dr. Cheng’s work stands at the intersection of artificial intelligence and human emotion, contributing to advancements in mental health technologies.

Profile

🎓 Education

Dr. Cheng Cheng received her Ph.D. in Computer Science from Dalian University of Technology in 2024, where her dissertation focused on EEG-based affective computing and mental health applications. During her doctoral studies, she specialized in deep learning, neural signal processing, and cross-domain adaptation models. Her academic training included a rigorous foundation in artificial intelligence, biomedical data analysis, and advanced computational neuroscience. Prior to her Ph.D., she completed her undergraduate and postgraduate studies in Computer Science with distinction, building a strong base in algorithm development and machine learning. Her education journey combined theoretical learning with practical projects and industry collaborations, preparing her for cross-disciplinary research in cognitive science. Through coursework, research assistantships, and conference participations, she gained expertise in cutting-edge neural decoding techniques, emotion modeling, and multimodal data fusion. Dr. Cheng continues to apply her educational background to develop innovative models that bridge brain signal processing and artificial intelligence.

🧪 Experience

Dr. Cheng Cheng is currently serving as a lecturer at the Brain and Cognitive Neuroscience Research Center, Liaoning Normal University, where she also leads a neuroscience and AI-integrated research lab. She has experience supervising postgraduate students, conducting collaborative research, and publishing peer-reviewed work in SCI-indexed journals. Her professional journey includes the development of the SASD-MCL framework for EEG-based emotion recognition and participation in multi-domain research initiatives aimed at improving mental health diagnostics. As a lab leader, she promotes interdisciplinary cooperation between neuroscientists and machine learning experts. Dr. Cheng has participated in national and university-funded research projects and regularly presents at conferences focused on cognitive computing and brain signal interpretation. Her previous roles include research assistantships during her doctoral program, where she refined her expertise in neural signal processing and cross-subject learning models. With a deep interest in innovation, she continues to enhance the accuracy and generalizability of emotion detection systems.

🏅 Awards and Honors

Dr. Cheng Cheng has been recognized for her outstanding contributions to affective computing and brain–AI interfacing. Her model SASD-MCL received academic commendation for significantly improving cross-subject EEG-based emotion recognition, achieving a 5.93% and 5.32% accuracy gain on SEED and SEED-IV datasets, respectively. She has received “Best Paper Presentation” at the International Conference on Cognitive Computing and Neural Interfaces and was awarded a Research Excellence Scholarship during her Ph.D. tenure. Her collaborative work on mental health diagnostics has been featured in top-tier journals, earning her invitations to join editorial boards and review panels. She is an active member of IEEE, the Chinese Association for Artificial Intelligence, and other neuroscience societies. Her leadership in mentoring young researchers and spearheading interdisciplinary projects has also been acknowledged by her institution. Nominated for the “Best Researcher Award,” Dr. Cheng continues to set benchmarks in neural data modeling, emotion AI, and computational mental health technologies.

🔬 Research Focus

Dr. Cheng Cheng’s primary research focus lies in affective computing, neural signal processing, and mental health assessment using EEG data. She integrates deep learning techniques with brain-computer interface (BCI) methodologies to improve the reliability and scalability of emotion recognition systems. Her SASD-MCL model, based on semi-supervised alignment and contrastive learning, addresses key challenges in cross-subject variability and label scarcity. By leveraging spatiotemporal features and multimodal EEG representations, she advances personalized and generalizable emotion detection systems. Her work also explores multi-domain adaptation and knowledge transfer in biomedical signal classification, enhancing robustness under limited supervision. Dr. Cheng’s research bridges neuroscience and artificial intelligence, contributing to innovations in automated mental health screening tools. She is currently involved in projects involving real-time emotion feedback and cognitive state monitoring using portable EEG devices. Her scientific vision aims to foster machine empathy through intelligent systems capable of understanding and responding to human emotions with clinical and social applications.

✅ Conclusion

Dr. Cheng Cheng exemplifies excellence in interdisciplinary research at the intersection of neuroscience and artificial intelligence. Her pioneering contributions to EEG-based emotion recognition and mental health assessment models offer robust, scalable solutions in affective computing. With a strong academic foundation, impactful innovations, and dedicated mentorship, she stands out as a deserving nominee for the Best Researcher Award.

Publications

Huifang Wang | Neuroscience | Best Researcher Award

Posted on by sciencefather

 Dr. Huifang Wang | Neuroscience | Best Researcher Award

Huifang Elizabeth Wang is a leading research engineer at INSERM U1106, Aix-Marseille University, France, specializing in computational neuroscience. Her career bridges robotics, brain modeling, and clinical neuroscience, with a primary focus on personalized brain simulations for neurological and psychiatric conditions, notably epilepsy. With over a decade of postdoctoral research across top French and Italian institutes, she has contributed to projects integrating physics-based modeling, large-scale neural dynamics, and effective connectivity. Her academic journey started in robotics and control theory in China and evolved into advanced brain modeling in Europe. She collaborates with renowned neuroscientists like Dr. Viktor Jirsa and has authored numerous high-impact publications in Science Translational Medicine, The Lancet Neurology, and NeuroImage. As PI and co-leader in several EU and national projects, she aims to bridge basic brain science with clinical translation. Wang’s work is pivotal in creating virtual brain twins to personalize epilepsy surgery and psychiatric interventions.

Profile

🎓 Education

Huifang Elizabeth Wang obtained her Ph.D. in Pattern Recognition and Intelligent Systems from Beijing University of Technology in 2008, focusing on optimization algorithms for robotic motion under Prof. Chen Yangzhou. She earned her M.S. from the same institution in 2003, researching advanced traffic control strategies. Her undergraduate degree (B.S.) in Electronic Engineering was awarded by Shandong Institute of Light Industry in 2000. Complementing her engineering foundation, she undertook a research visit at LAAS-CNRS in Toulouse in 2007, developing time-optimal trajectories for car-like robots. Currently, she is finalizing her HDR (Habilitation à Diriger des Recherches) at Aix-Marseille University (Nov 2024) under the supervision of Dr. Viktor Jirsa, with a thesis on “Virtual Brain Twins.” Her education spans multiple disciplines and institutions, combining engineering, neuroscience, and clinical modeling. This interdisciplinary background underpins her leadership in personalized neural modeling and translational neuroscience research.

🧪 Experience

Wang is a Research Engineer at INSERM U1106, Aix-Marseille University (2017–present), leading work on virtual brain twins for clinical use in epilepsy and psychiatry. Prior, she was a Postdoc at the Institut du Cerveau (ICM), Paris (2016–2017), studying human neuron behavior with Pr. Vincent Navarro. At École des Mines de Saint-Étienne (2016), she helped develop a physiological SEEG atlas. From 2012–2016, she worked at INSERM U1106 on brain connectivity under Drs. Bernard and Jirsa. Earlier, she researched robotic control and planning at the University of Pisa (2008–2010) in Prof. Antonio Bicchi’s group. Her expertise spans brain modeling, robotics, and neuroscience, with leadership in multi-institutional EU-funded projects. She has served as PI and co-leader in several major efforts like the Human Brain Project and EPINOV. Her interdisciplinary experience uniquely equips her to bridge theory, technology, and medicine in brain modeling applications.

🏅 Awards and Honors

Huifang Elizabeth Wang has earned prestigious research roles and leadership positions in major European and national initiatives. She is PI for the AMIDEX-funded HR-VEP project and WP4 leader in the Horizon RIA Virtual Brain Twin initiative (2024–2027). Her projects have been supported by the Human Brain Project, France 2030, and Horizon Europe. She served as co-task leader in HBP’s epilepsy-focused work packages and trial coordinator in EPINOV RHU, a national clinical modeling trial. Her work on brain modeling has been published in high-impact journals, underscoring her scientific excellence. She has collaborated with pioneers like Karl Friston and Viktor Jirsa, advancing the fields of functional connectivity and computational neuroscience. Additionally, she has been granted funding by institutions such as Fondation Recherche Médicale and Ligue Française contre l’Épilepsie, recognizing her contributions to translational neuroscience and computational modeling in clinical applications.

🔬 Research Focus

Wang’s research centers on developing personalized virtual brain models to understand and treat brain disorders such as epilepsy and psychiatric conditions. She specializes in large-scale neural modeling using neural mass and field models, enabling individual-specific simulations—a concept known as “virtual brain twins.” Her work integrates multimodal neuroimaging data (e.g., SEEG, MRI) with computational frameworks to predict surgical outcomes and guide interventions. As part of projects like VEP Atlas, EPINOV, and EBRAINS, she builds anatomical-functional atlases for clinical use. She also advances Bayesian techniques for parameter estimation in brain modeling. Her research bridges basic neuroscience with translational applications, using virtual brains to delineate epileptogenic zones and simulate drug-resistant epilepsy spread. In psychiatric disorders, her focus includes simulating and analyzing network dysfunction to support precision psychiatry. By blending machine learning, dynamical systems, and neuroinformatics, Wang’s work pioneers a new frontier in personalized medicine using brain simulations.

✅ Conclusion

Dr. Huifang Elizabeth Wang is an interdisciplinary researcher transforming clinical neuroscience through virtual brain modeling, combining engineering precision with neuroscientific insight. Her pioneering work in virtual brain twins supports individualized diagnosis and treatment of epilepsy and psychiatric disorders, representing a significant advance in precision medicine. With extensive experience, numerous publications, and leadership in high-impact research projects, she bridges theory and practice. Her scientific vision and collaborative leadership continue to shape the future of computational neuroscience and neurotechnology for patient care worldwide.

Publications

Jinming yang | Remote sensing disaster detection | Best Researcher Award

Posted on by sciencefather

Assist. Prof. Dr. jinming yang | Remote sensing disaster detection | Best Researcher Award

Dr. JinMing Yang is an Assistant Researcher at the Xinjiang Institute of Ecology and Geography, Chinese Academy of Sciences. With a Ph.D. in Geography from Xinjiang University, his expertise lies in snow ecohydrology and disaster science in arid regions. His research integrates physical experiments, remote sensing technologies, and mathematical modeling to study snow and avalanche phenomena, focusing on precipitation-ice-snow runoff processes and snow disaster assessment. He has developed advanced remote sensing models for detecting avalanche debris and contributed significantly to understanding the dynamic evolution of mountain disasters. He has published influential articles in SCI-indexed journals, including innovations in automatic avalanche detection using C-band SAR data. He serves as a reviewer for Cold Regions Science and Technology and holds membership in the Xinjiang Natural Resources Society. His scientific contributions are helping to improve snow safety and disaster risk management, making him a prominent figure in his field.

Profile

🎓 Education

Dr. JinMing Yang earned his Ph.D. in 2017 from Xinjiang University, China, majoring in Geography with a specialization in Physical Geography. His doctoral studies provided a strong foundation in environmental and geospatial sciences, with a specific focus on the cryosphere in arid regions. He received intensive training in field-based observation, experimental research, remote sensing data analysis, and mathematical modeling techniques. Throughout his academic career, he has demonstrated a high level of scientific rigor and innovation, especially in integrating electromagnetic spectrum characteristics with snow and avalanche studies. His education combined theoretical depth with applied research, equipping him with the skills to investigate ecohydrological processes, snow accumulation dynamics, and avalanche risk modeling. This academic background not only enhanced his capacity for independent research but also prepared him for interdisciplinary collaborations aimed at understanding and mitigating natural disasters in vulnerable mountainous terrains.

🧪 Experience

Since completing his Ph.D., Dr. JinMing Yang has served as an Assistant Researcher at the Xinjiang Institute of Ecology and Geography, Chinese Academy of Sciences. He has accumulated significant experience in snow ecohydrology, particularly within arid and mountainous environments. His work centers on monitoring and modeling snow-related hazards using advanced remote sensing technologies, including SAR data, to improve avalanche detection accuracy. He led a National Natural Science Foundation of China project focused on spatiotemporal evolution of avalanches in the western Tianshan Mountains, employing multi-modal electromagnetic spectrum coupling. Dr. Yang has also contributed to disaster risk assessment frameworks and snow safety strategies, often working with cross-disciplinary teams. His methodological expertise in fusing remote sensing, geostatistics, and simulation models makes him an asset in both academic and practical contexts. Additionally, his editorial and peer-review contributions reflect his growing leadership in the cryosphere and natural hazards research community.

🏅 Awards and Honors

Dr. JinMing Yang has emerged as a notable young researcher in the field of snow disasters and mountain hazard assessment. While specific awards are not listed in the provided information, his nomination for the “Best Researcher Award” highlights his recognized excellence and impact in scientific research. His groundbreaking work on avalanche detection using SAR data and multi-source model integration has earned him reviewer responsibilities for prestigious journals like Cold Regions Science and Technology. His citation index of 29 indicates growing academic recognition, and his project funding from the National Natural Science Foundation of China signifies trust in his expertise and innovative capacity. His active role in professional societies like the Xinjiang Natural Resources Society further reflects his integration into influential academic networks. His contributions are instrumental in shaping practical policies for snow safety in arid mountain environments, positioning him as a strong candidate for national and international research accolades.

🔬 Research Focus

Dr. JinMing Yang’s research is focused on snow ecohydrology and disaster risk modeling in arid and mountainous regions, with snow as the central element. He explores the precipitation-ice-snow runoff process and studies the mechanisms driving avalanche formation and development. A major aspect of his work involves remote sensing-based detection and assessment of snow disasters, particularly the use of SAR data to automate avalanche debris identification. His innovative research has led to the development of independently constructed models combining multi-source variables to quantify avalanche risk spatially and temporally. He also investigates the seasonal dynamics and causal variable influences on avalanche behavior, contributing to mountain safety science. These models offer insights into hazard evolution, aiding in effective disaster prevention and response. His methodology relies heavily on geospatial analysis, electromagnetic spectrum modeling, and simulation techniques, bridging theoretical understanding with real-world applications for environmental safety and planning.

✅ Conclusion

Dr. JinMing Yang stands out as an accomplished researcher whose innovative contributions to snow ecohydrology and remote sensing-based disaster assessment have advanced scientific understanding and practical management of snow-related hazards in arid mountain regions.

Publications

  • Dynamic spatiotemporal quantification of avalanches in the Central Tianshan Mountains by integrating air–space–ground collaborative sensing and snow field–terrain filters

    International Journal of Digital Earth
    2024-12-31 | Journal article
    DOI: 10.1080/17538947.2024.2432525
    Part ofISSN: 1753-8947
    Part ofISSN: 1753-8955
    CONTRIBUTORS: JinMing Yang; LanHai Li; Yang Liu

  • Moderate-resolution snow depth product retrieval from passive microwave brightness data over Xinjiang using machine learning approach

    International Journal of Digital Earth
    2024-12-31 | Journal article
    DOI: 10.1080/17538947.2023.2299208
    Part ofISSN: 1753-8947
    Part ofISSN: 1753-8955
    CONTRIBUTORS: Yang Liu; Jinming Yang; Xi Chen; Junqiang Yao; Lanhai Li; Yubao Qiu

  • Snow avalanche susceptibility mapping from tree-based machine learning approaches in ungauged or poorly-gauged regions

    CATENA
    2023-05 | Journal article
    DOI: 10.1016/j.catena.2023.106997
    Part ofISSN: 0341-8162
    CONTRIBUTORS: Yang Liu; Xi Chen; Jinming Yang; Lanhai Li; Tingting Wang

  • Winter–Spring Prediction of Snow Avalanche Susceptibility Using Optimisation Multi-Source Heterogeneous Factors in the Western Tianshan Mountains, China

    Remote Sensing
    2022-03-10 | Journal article
    DOI: 10.3390/rs14061340
    Part ofISSN: 2072-4292
    CONTRIBUTORS: Jinming Yang; Qing He; Yang Liu

  • Mapping snow avalanche debris by object-based classification in mountainous regions from Sentinel-1 images and causative indices

    CATENA
    2021-11 | Journal article
    DOI: 10.1016/j.catena.2021.105559
    Part ofISSN: 0341-8162
    CONTRIBUTORS: Yang Liu; Xi Chen; Yubao Qiu; Jiansheng Hao; Jinming Yang; Lanhai Li

  • Assimilation of D-InSAR snow depth data by an ensemble Kalman filter

    Arabian Journal of Geosciences
    2021-03 | Journal article
    DOI: 10.1007/s12517-021-06699-y
    Part of ISSN: 1866-7511
    Part of ISSN: 1866-7538
    CONTRIBUTORS: Jinming Yang; Chengzhi Li

Ronald Castelino | Nephrology | Best Researcher Award

Posted on by sciencefather

Assoc. Prof. Dr. Ronald Castelino | Nephrology | Best Researcher Award

Head of Pharmacy Practice, University of Sydney, Australia

Ronald L. Castelino, BPharm, MPharm, PhD, PDCR, MSHPA, is an Associate Professor in Pharmacology & Clinical Pharmacy at the University of Sydney and an Adjunct Senior Lecturer at the University of Tasmania. With a strong academic foundation and global experience in clinical pharmacy, especially nephrology, he focuses on the quality use of medicines in chronic diseases. His academic journey spans India and Australia, backed by leadership in teaching and translational research. He contributes extensively to nursing and pharmacy education while holding an active pharmacist role at Blacktown Hospital. Dr. Castelino has co-supervised multiple postgraduate research projects, published over 90 papers, and leads a research group focused on kidney disease management and medication safety. He is Board Certified in Geriatric Pharmacy and a Fellow of the Australia and New Zealand College of Advanced Pharmacy. A passionate educator, clinician, and researcher, he embodies a multidisciplinary approach to advancing pharmacy practice and patient-centered care.

Profile

🎓 Education

Dr. Ronald Castelino holds a PhD in Pharmacy Practice from the University of Sydney (2011), an MPharm in Pharmacy Practice (2006), and a BPharm (2003) from Rajiv Gandhi University of Health Sciences, Bangalore, India. He also completed a Professional Diploma in Clinical Research (PDCR, 2006) and is Board Certified in Geriatric Pharmacy (BCGP, 2018). In 2024, he was honored as a Fellow of the Australia and New Zealand College of Advanced Pharmacy (FANZCAP) for his contributions to nephrology and research. His educational achievements are distinguished with high academic honors, including a Gold Medal and Second Rank in his MPharm degree. This diverse educational background underpins his extensive work in clinical pharmacology, research methodology, and teaching. His academic preparation reflects a balance of clinical training, research competence, and leadership in the pharmaceutical sciences. These qualifications have enabled him to impact pharmacy education and practice across undergraduate, postgraduate, and professional levels.

🧪 Experience

Dr. Castelino has held progressive academic and clinical roles across India and Australia. He is currently Associate Professor at the University of Sydney (since 2023) and previously served as Senior Lecturer (2016–2022) and Lecturer at the University of Tasmania (2011–2016). His clinical experience includes roles as Renal Pharmacist at Blacktown Hospital (NSW, since 2016), Pharmacist at Calvary Health Care Tasmania (2012–2015), Clinical Educator at Royal Hobart Hospital, and Clinical Pharmacist in India (2004–2007). He has tutored at the University of Sydney (2008–2011) and coordinated various undergraduate and postgraduate subjects in pharmacy and nursing, including pharmacology, therapeutics, and evidence-based practice. Dr. Castelino has also served on scientific committees and has been instrumental in supervising PhD and MPhil candidates. His dual expertise in clinical pharmacy and academia supports a translational approach to patient care and education, positioning him as a bridge between hospital practice and academic advancement in medication safety and chronic disease management.

🏅 Awards and Honors

Dr. Ronald Castelino has received numerous accolades throughout his academic and professional career. He was awarded the Teaching Merit Certificate by the University of Tasmania in both 2013 and 2014 for excellence in education. His outstanding academic performance was recognized with the Second Rank in MPharm (Pharmacy Practice) by Rajiv Gandhi University of Health Sciences, Bangalore, India (2006). He was also the Gold Medallist and Best Outgoing Student at JSS College of Pharmacy, Mysore (2004–2005). In recognition of his expertise and leadership in nephrology and pharmacy research, he became a Fellow of the Australia and New Zealand College of Advanced Pharmacy (FANZCAP) in 2024. These awards underscore his commitment to advancing pharmacy practice, medical education, and health services research. His consistent recognition reflects both academic excellence and sustained contributions to pharmacy education, making him a highly respected educator and clinician in his field.

🔬 Research Focus

Dr. Castelino’s research centers on the quality use of medicines and chronic disease state management, particularly in kidney diseases. He leads a multidisciplinary research group at the University of Sydney dedicated to medication safety and health service improvement in nephrology. His translational research aligns with the University’s theme of “Better Health” and includes pharmacist-led medication review clinics, studies on metformin use in diabetes, and adverse drug reactions in elderly patients. He has supervised several PhD and MPhil students, with projects targeting medication regimen complexity in end-stage kidney disease and healthcare delivery models. Dr. Castelino’s work is informed by his clinical practice as a renal pharmacist and aims to bridge gaps between patient care and policy implementation. With over 97 publications, including book chapters and professional articles, his research has influenced both academic and hospital-based pharmacy practices. His focus remains on evidence-based interventions that enhance safety and outcomes in vulnerable populations.

✅ Conclusion

Dr. Ronald Castelino exemplifies the integration of academic excellence, clinical expertise, and research leadership in pharmacy practice. Through his commitment to improving medication safety and chronic disease management, he bridges gaps between education, research, and patient care. His contributions continue to shape pharmacy education and nephrology research in Australia and beyond.

 

Publications

Yi Zhang | Obesity and Inhibitory-control | Best Researcher Award

Posted on by sciencefather

Dr. Yi Zhang | Obesity and inhibitory-control | Best Researcher Award

Professor, Xidian University, China

Dr. Yi Zhang is a distinguished neuroscientist and professor at the School of Life Science and Technology, Xidian University, China, where he also directs the Center for Brain Imaging. Born in Xi’an, Shaanxi, China, in 1980, Dr. Zhang has dedicated his academic and research career to exploring the brain’s mechanisms using advanced neuroimaging tools. With a PhD in Pattern Recognition and Intelligent Systems, he combines engineering and neuroscience to investigate conditions like obesity, addiction, and acupuncture effects. He has published over 80 journal articles and served on editorial boards of several high-impact journals. His work emphasizes functional MRI, brain modulation, and neurofeedback to improve cognitive and behavioral health. Recognized with multiple national awards, Dr. Zhang has also served as a visiting scholar in the U.S. and holds memberships in prestigious global neuroscience and medical imaging societies. His research continues to drive innovation in non-invasive brain intervention and signal processing techniques.

Profile

🎓 Education

Dr. Yi Zhang’s academic journey is rooted in Xidian University, Xi’an, China, where he earned his Bachelor’s degree in Electronic Engineering in 2003. He continued his postgraduate studies in the same institution, receiving his Master’s degree in 2006 and PhD in 2009 in Pattern Recognition and Intelligent Systems, focusing on integrating engineering and intelligent control with neural research. His passion for bridging technology and life sciences led him to further his academic exposure abroad. From 2010 to 2011, he was a visiting scholar at the Department of Psychiatry and McKnight Brain Institute at the University of Florida College of Medicine in the United States. This international experience broadened his expertise in functional MRI and advanced medical imaging. His multidisciplinary educational background has laid a strong foundation for his research in brain imaging, signal processing, and behavioral neuroscience, allowing him to contribute significantly to understanding neural mechanisms in health and disease.

🧪 Experience

Dr. Yi Zhang has had a progressive academic career at Xidian University, starting as a Teaching Assistant in the School of Electronic Engineering (2006–2008), followed by roles as Lecturer (2008–2010), Associate Professor (2010–2015), and Professor since 2015 at the School of Life Science and Technology. His teaching has been complemented by his leadership as Director of the Center for Brain Imaging, where he spearheads interdisciplinary research projects. He has collaborated internationally as a visiting scholar at the University of Florida, enhancing his global perspective in brain imaging. His professional contributions encompass mentoring, publishing, and developing cutting-edge research on obesity, addiction, acupuncture, and real-time neurofeedback. Dr. Zhang has also held key editorial and organizational roles, showcasing his dedication to academic excellence. With over 15 years of continuous experience, he remains a prominent figure in neuroimaging, blending teaching and research to cultivate innovation in neuroscience and intelligent systems.

🏅 Awards and Honors

Dr. Yi Zhang has been the recipient of several prestigious national and institutional honors in recognition of his contributions to neuroscience and medical imaging. In 2022, he received the First Prize of the Shaanxi Higher Education Science and Technology Award for his research on brain modulation in obese patients. His work on acupuncture mechanisms using fMRI earned him First and Second Prizes from the China Society for Stereo Vision and Beijing Natural Science Award in 2015 and 2014, respectively. He was named an Early Career Investigator under the “Hua Mountain Scholar Program” in 2014 and by NIDA’s mini-convention in 2011. Additional accolades include First Prizes from the Shaanxi Higher Education and second prize from the Provincial Science and Technology Award in 2011. These recognitions affirm his innovative work in functional neuroimaging and its applications in cognitive enhancement, pain management, and behavioral intervention. His research continues to garner attention and impact across disciplines.

🔬 Research Focus

Dr. Yi Zhang’s research lies at the intersection of brain science, medical imaging, and behavioral neuroscience. His primary focus is the application of functional Magnetic Resonance Imaging (fMRI) to investigate brain activity in conditions like obesity, heroin addiction, and acupuncture. As Director of the Center for Brain Imaging, he leads studies on real-time neurofeedback to modulate brain functions, especially appetite and reward mechanisms. His work aims to decode neural patterns and develop interventions that influence behavior and cognition. With an engineering background, he also develops advanced signal processing algorithms to handle dynamic, multivariate neurobiological data. His interdisciplinary approach has helped bridge neuroscience and intelligent systems, enabling novel therapeutic strategies. Dr. Zhang’s research has influenced fields like psychopharmacology, neurofeedback therapy, and brain modulation, providing insights into the biological basis of behavior and supporting non-invasive treatment strategies. He has co-authored over 80 journal papers, affirming his position as a leader in neuroimaging innovation.

✅ Conclusion

Dr. Yi Zhang stands out as a visionary neuroscientist whose interdisciplinary expertise in engineering and life sciences advances brain imaging and cognitive neuroscience. Through pioneering research in fMRI, neurofeedback, and brain modulation, he addresses critical health issues like obesity, addiction, and pain. With a distinguished academic record, numerous awards, and a global scholarly presence, Dr. Zhang continues to shape the future of neuroscience research and education through his leadership, innovation, and dedication to improving human health.

Publications

  • A hybrid network integrating convolution and transformer for thymoma segmentation

    Intelligent Medicine
    2023-08 | Journal article
    DOI: 10.1016/j.imed.2022.06.003
    CONTRIBUTORS: Jingyuan Li; Wenfang Sun; Xiulong Feng; Karen M. von Deneen; Wen Wang; Guangbin Cui; Yi Zhang

  • MG-Net: Multi-level global-aware network for thymoma segmentation

    Computers in Biology and Medicine
    2023-03 | Journal article
    DOI: 10.1016/j.compbiomed.2023.106635
    CONTRIBUTORS: Jingyuan Li; Wenfang Sun; Karen M. von Deneen; Xiao Fan; Gang An; Guangbin Cui; Yi Zhang

  • Electroacupuncture enhances resting-state functional connectivity between dorsal caudate and precuneus and decreases associated leptin levels in overweight/obese subjects

    Brain Imaging and Behavior
    2022-02 | Journal article
    DOI: 10.1007/s11682-021-00519-3
    CONTRIBUTORS: Yang He; Karen M. von Deneen; Guanya Li; Borong Jing; Yanyan Zhou; Kaiya Zhang; Yi Zhang; Yuanyuan

  • A dense connection encoding–decoding convolutional neural network structure for semantic segmentation of thymoma

    Neurocomputing
    2021-09 | Journal article
    DOI: 10.1016/j.neucom.2021.04.023
    CONTRIBUTORS: Jingyuan Li; Wenfang Sun; Xiulong Feng; Gang Xing; Karen M. von Deneen; Wen Wang; Yi Zhang; Guangbin Cui

Adithi Randeni | Transcytosis Mechanisms and Hydrocephalus Pathophysiology | Best Researcher Award

Posted on by sciencefather

Dr. Adithi Randeni | Transcytosis Mechanisms and Hydrocephalus Pathophysiology | Best Researcher Award

Leeds Teaching Hospitals Trust, United Kingdom

Dr. Randeni A. Adithi H. Randeni is a Foundation Year One doctor at Leeds Teaching Hospital Trust with a dynamic portfolio in clinical research, innovation, and academic leadership. A graduate of the University of Leeds (MBChB), she has gained international exposure through observerships and research collaborations in the UK and USA, including SUNY Upstate. Her scholarly contributions span neurosurgery, cerebrospinal fluid dynamics, and biomedical innovation, with publications in top-tier journals such as IJMS, BJS, and BMC Medical Education. Dr. Randeni has received numerous awards and bursaries and is an active educator and mentor. Her leadership roles in university bodies and national societies reflect her commitment to academic excellence and inclusivity. With a future goal of specializing in neurosurgery, she aims to contribute to translational research and advance surgical practice globally through innovation and collaboration.

Profile

🎓 Education

Dr. Adithi Randeni earned her Bachelor of Medicine and Bachelor of Surgery (MBChB) from the University of Leeds, where she excelled in both academic and research endeavors. Her education was enriched by multiple research projects and electives across the UK and internationally, including SUNY Upstate Medical University in the USA. During her time at Leeds, she engaged deeply with translational research, contributing to projects on hydrocephalus, tissue engineering, neurotrauma, and breast cancer genetics. Her academic training included structured research programs and specialized modules in biomedical innovation, CSF dynamics, and advanced surgical techniques. She also undertook audits, systematic reviews, and service evaluations during clinical placements. Beyond formal education, she participated in national research fellowships and student interest groups that fostered interdisciplinary learning and mentorship. Dr. Randeni’s educational journey reflects a strong integration of clinical knowledge with scientific inquiry, preparing her for a future as a research-driven neurosurgeon and academic leader.

🧪 Experience

Dr. Adithi Randeni currently serves as a Foundation Year One doctor at Leeds Teaching Hospital Trust, where she is engaged in hands-on patient care, audits, and quality improvement projects. She has amassed extensive research experience through clinical, translational, and lab-based projects, including those at SUNY Upstate and the University of Leeds. Her past roles include conducting systematic reviews, performing service evaluations in neurosurgery, and leading national student surveys like SMART. She has presented her findings at both national and international conferences and has co-authored peer-reviewed articles and a book chapter. In addition to clinical duties, she has held leadership roles in student organizations, served as a medical student representative, and organized educational workshops. Her involvement with professional societies and interdisciplinary teams highlights her ability to balance clinical work, academic productivity, and collaborative initiatives, making her a well-rounded early-career professional with a clear trajectory in neurosurgical research and innovation.

🏅 Awards and Honors

Dr. Adithi Randeni has been the recipient of numerous academic awards, conference bursaries, and leadership recognitions during her medical training. Her achievements include international presentation opportunities and publication accolades for research on hydrocephalus, surgical outcomes, and student engagement in research pathways. She was invited to co-author a chapter in Springer’s “Arachnoid Cysts: State-of-the-Art” and has contributed to high-impact journals like the British Journal of Surgery and BMC Medical Education. She has earned research travel grants, elective placement scholarships, and teaching recognitions for organizing peer education workshops. Active in student leadership, she received commendations for her roles within the Medical Student Representative Council and societies such as NANSIG and the National MedTech Foundation. Her selection for the “Best Researcher Award” nomination reflects her growing influence in academic medicine. These honors affirm her commitment to excellence in research, innovation, and medical education at an early stage of her professional journey.

🔬 Research Focus

Dr. Adithi Randeni’s research focus lies at the intersection of neurosurgery, cerebrospinal fluid (CSF) dynamics, and biomedical innovation. She has explored pathological mechanisms such as abnormal transcytosis in hydrocephalus, authored a chapter on the genetics of arachnoid cysts, and is actively investigating CSF composition in hydrocephalus through collaborations with SUNY Upstate. Her research interests also include neurotrauma, surgical outcomes, antimicrobial stewardship, and tissue-engineered cardiovascular grafts. With a strong inclination toward translational research, she integrates clinical insights with lab-based findings to drive innovation. Dr. Randeni also explores medical education, having co-led the SMART study on student engagement in research. Her contributions aim to bridge the gap between bedside care and bench science, with ongoing work assessing surgical site infections and diagnostic accuracy in neurosurgical imaging. She is passionate about leveraging biomedical research and digital tools to enhance patient outcomes and surgical practice, particularly in underserved and complex neurological conditions.

✅ Conclusion

Dr. Adithi Randeni exemplifies the fusion of clinical excellence, research innovation, and educational leadership, positioning her as a promising future leader in neurosurgery and translational science.

Publications

  • Abnormal Transcytosis Mechanisms in the Pathogenesis of Hydrocephalus: A Review

    International Journal of Molecular Sciences
    2025-05-19 | Journal article
    DOI: 10.3390/ijms26104881
    Part ofISSN: 1422-0067
    CONTRIBUTORS: Adithi Randeni; Sydney Colvin; Satish Krishnamurthy

  • Genetics of Arachnoid Cysts

    Arachnoid Cysts
    2023 | Book chapter
    DOI: 10.1007/978-3-031-22701-1_8
    Part ofISBN: 9783031227004
    Part ofISBN: 9783031227011
    CONTRIBUTORS: Adithi Randeni; Sydney Colvin; Satish Krishnamurth

  • Cross-sectional Survey of Medical student perceptions of And desires for Research and Training pathways (SMART): an analysis of prospective cohort study of UK medical students

    BMC Medical Education
    2023-12-15 | Journal article
    DOI: 10.1186/s12909-023-04881-2
    Part of ISSN: 1472-6920
    CONTRIBUTORS: Gokul Parameswaran; Amelia Bowman; Catherine Swales; Setthasorn Zhi Yang Ooi; Shie Wei Chan; Priya Rose Babu; Daniele Ramsay; Sofia Kostoudi; Soham Bandyopadhyay; SMART-NANSIG-InCiSion Collaborative et al.

Timea Claudia Ghitea | Metabolic Syndrome | Women Researcher Award

Posted on by sciencefather

Dr. Timea Claudia Ghitea | Metabolic Syndrome | Women Researcher Award

Universitary Assistant, University of Oradea, Romania

GHITEA TIMEA-CLAUDIA is a Romanian expert in pharmacy and clinical nutrition, with over two decades of professional experience combining pharmaceutical practice, clinical and sports nutrition, and academic teaching. She currently serves as a university assistant at the Faculty of Medicine and Pharmacy in Oradea and leads nutrition initiatives at Echo Laboratories. Her career began in 1999 as a pharmacy assistant, advancing through key leadership roles, including pharmacist director in various pharmacies. Holding dual specialization in pharmacy and biomedical sciences, Dr. Ghitea completed her doctorate in Clinical and Sports Nutrition in 2020. A multilingual professional, she is committed to interdisciplinary collaboration and student mentorship. Her dynamic profile is strengthened by memberships in national and international professional societies. She also contributes actively to administrative roles in academic and pharmaceutical organizations. Dr. Ghitea is a respected voice in the evolving field of clinical nutrition and personalized healthcare in Romania.

Profile

🎓 Education

GHITEA TIMEA-CLAUDIA holds a robust academic portfolio encompassing both pharmaceutical and biomedical disciplines. She earned her Doctorate in Biomedical Sciences with a focus on Clinical and Sports Nutrition in 2020 and completed postgraduate studies in Nutrition and Dietetics in 2017. Her foundational studies include a Master’s degree in Cell Biology (2006), a Pharmacy degree from the Faculty of Medicine and Pharmacy in Oradea (2006), and a Bachelor of Science in Biology-Chemistry (2002). She also holds a diploma as a Pharmacy Assistant from the Vasile Voiculescu Post-High School (1999) and graduated high school from Ady Endre Theoretical High School in 1997. She has continuously enhanced her expertise through specializations such as a residency in Clinical Pharmacy (2009) and various professional training programs. Her academic involvement is complemented by her roles in professional boards and committees, contributing significantly to pharmacy and nutrition education in Romania.

🧪 Experience

GHITEA TIMEA-CLAUDIA brings more than 25 years of hands-on experience in pharmacy, healthcare, and academia. Since 2017, she has served as a university assistant at the Faculty of Medicine and Pharmacy, Oradea, while also leading clinical and sports nutrition services at Echo Laboratories. Previously, she was pharmacist director at Serbien Pharmacy (2012–2017) and MIG3 Pharmacy (2011–2012). Her career began as a pharmacy assistant at Delia Pharmacy (1999–2006), followed by a pharmacist role at Fontana Pharmacy (2006–2011). A proactive mentor and project leader, she supervises internships and facilitates interdisciplinary collaboration to address complex patient cases in nutrition. Her leadership extends to project management and service coordination in clinical nutrition. Her deep understanding of pharmacy and dietetics, combined with strong communication, organizational, and mentoring skills, ensures her consistent contribution to healthcare innovation and medical education. She effectively bridges academic knowledge with clinical application and professional governance.

🏅 Awards and Honors

GHITEA TIMEA-CLAUDIA has earned recognition through key leadership roles and active participation in prominent professional associations. She was appointed President of the Discipline Committee at the College of Pharmacists, Bihor, in 2011, and later served as a member of both the General Assembly and the Discipline Committee. Her involvement spans national and international professional societies, including the American Society for Nutrition (2017), the Romanian Society of Pharmaceutical Sciences (2019), and the Pharmacological Association of Romania (since 2006). She is also a member of the Nutritionists Association of Romania (2022) and the Society of Pharmaceutical History Romania (2019). Her consistent efforts in academic mentorship earned her the role of Internship Mentor, and she was designated Project Manager in 2022. These accolades underscore her leadership, dedication to advancing pharmacy and nutrition sciences, and her commitment to mentoring future professionals. Her honors reflect a sustained contribution to both clinical practice and scholarly engagement.

🔬 Research Focus

Dr. GHITEA TIMEA-CLAUDIA’s research focus lies at the intersection of clinical pharmacy, sports nutrition, and biomedical science. Her work is dedicated to optimizing patient care through evidence-based nutritional strategies and the integration of pharmaceutical knowledge into personalized dietetic plans. Her doctoral studies in Clinical and Sports Nutrition laid the foundation for a research trajectory that includes metabolic optimization, nutritional therapy in chronic diseases, and the role of diet in athletic performance and recovery. She actively collaborates with international colleagues to solve complex clinical nutrition cases and contributes to interdisciplinary projects aimed at enhancing nutritional interventions. As a university assistant and project leader, she mentors students in clinical research methodology, practical case-solving, and the application of nutritional science in medical contexts. Her expertise is instrumental in bridging academic insights with real-world patient outcomes, promoting innovation in clinical nutrition and pharmacy-driven healthcare models.

✅ Conclusion

Dr. Ghitea Timea-Claudia is a dynamic healthcare professional whose career seamlessly bridges pharmaceutical science, clinical nutrition, and academic leadership. Her vast experience, ongoing research, and dedication to student mentorship reflect her holistic and forward-thinking approach to health education and patient care.

Publications

  • Vaccine Adherence: From Vaccine Hesitancy to Actual Vaccination and Reasons for Refusal of Childhood Vaccines in a Group of Postpartum Mothers

    In Vivo
    2025 | Journal article
    DOI: 10.21873/INVIVO.13855
    WOSUID: WOS:001391824800006
    CONTRIBUTORS: Iova, Camelia florina; Daina, Lucia georgeta; Ilea, Codrin dan nicolae; Domnariu, Horatiu Paul; Ghitea, Timea claudia; Daina, Madalina Diana Daina

  • The Impact of Thrombophilia on Maternal and Neonatal Outcomes: A Multisystem Analysis of Clinical, Hematological, and Metabolic Parameters

    Journal of Clinical Medicine
    2025-05-23 | Journal article
    DOI: 10.3390/jcm14113665
    CONTRIBUTORS: Viorela-Romina Murvai; Radu Galiș; Cristina-Maria Macrea; Anca-Florina Tărău-Copos; Marius Daniel Goman; Timea Claudia Ghitea; Anca Huniadi

  • Stomatognathic Dysfunction and Neuropsychological Imbalance: Associations with Salivary Cortisol, EMG Activity, and Emotional Distress

    Dentistry Journal
    2025-05-22 | Journal article
    DOI: 10.3390/dj13060230
    CONTRIBUTORS: Ioana Scrobota; Liliana Sachelarie; Timea Claudia Ghitea; Georgiana Ioana Potra Cicalau; Roxana Alexandra Cristea; Pelea Diana; Petra Saitos; Alexandra Vlad; Loredana Liliana Hurju

  • Correlation Between Vitamin D Deficiency (25(OH)D3) and the Severity of Purulent Oropharyngeal Infections

    Journal of Clinical Medicine
    2025-04-01 | Journal article
    DOI: 10.3390/jcm14072410
    CONTRIBUTORS: Florian Ciprian Venter; Timea Claudia Ghitea; Adrian Nicolae Venter; Amin-Florin El-kharoubi; Mousa El-kharoubi; Evelin Claudia Ghitea; Marc Cristian Ghitea; Amina Vente

  • Psychological Distress and Quality of Life in Patients with Colon Cancer: Predictors, Moderating Effects, and Longitudinal Impact

    Healthcare
    2025-03-27 | Journal article
    DOI: 10.3390/healthcare13070753
    CONTRIBUTORS: Lavinia Alina Rat; Timea Claudia Ghitea; Adrian Marius Maghiar

Habibullah Eatamadi | Thyroid eye disease | Best Researcher Award

Posted on by sciencefather

Dr. Habibullah Eatamadi | Thyroid eye disease | Best Researcher Award

Consultant Oculoplastic Surgeon, Sheikh Shakhbout Medical City, United Arab Emirates

Dr. Habibullah Eatamadi is a distinguished Consultant Oculoplastics, Lacrimal, and Orbital Surgeon with extensive experience in both clinical practice and academic leadership. Born on February 3, 1968, he holds Irish nationality and is registered with multiple medical councils, including the UAE DOH and the UK GMC. He has served in leading ophthalmic institutions across the UK and UAE, such as Sheikh Shakhbout Medical City and Sheikh Khalifa Medical City. His fellowships in Oculoplastics and Pediatric Ophthalmology from top UK hospitals have shaped his expertise in complex surgeries. He is a member of prestigious societies like ASOPRS, BOPSS, and the AAO. Known for his compassionate care and dedication to innovation, Dr. Eatamadi is actively involved in teaching, clinical audits, and presenting at global conferences. His leadership in ophthalmology has had a transformative impact on eye care services in the UAE.

Profile

🎓 Education

Dr. Eatamadi completed his MD from Albert Szent Gyorgyi Medical University, Szeged, Hungary, in 1993. His postgraduate education includes a specialty degree in Ophthalmology from Haynal Imre Postgraduate Medical University, Budapest, in 1997, followed by the FRCS in Ophthalmology from the Royal College of Surgeons, Edinburgh, in 1999. To complement his clinical expertise with administrative acumen, he pursued a Master’s degree in Healthcare Management from Zayed University in collaboration with North Carolina University in 2014. His education reflects a well-rounded foundation in both medical science and healthcare leadership. He holds full registrations with the Irish Medical Council (IMC), UK General Medical Council (GMC), and the UAE Department of Health. Dr. Eatamadi’s continuous pursuit of knowledge through fellowships and academic programs has been pivotal in shaping his subspecialty focus on Oculoplastics, Lacrimal, and Orbital Surgery. His academic background demonstrates both depth and breadth in clinical medicine and healthcare systems.

🧪 Experience

Dr. Habibullah Eatamadi has over two decades of international clinical experience in ophthalmology, particularly in Oculoplastics, Lacrimal, and Orbital Surgery. He currently serves as Consultant Ophthalmic Surgeon at Sheikh Shakhbout Medical City, UAE, since December 2020. Previously, he was Head of the Department at Sheikh Khalifa Medical City (2011–2020) and Consultant at Tawam Hospital (2008–2011). His fellowship training across top UK hospitals, including the Western Eye Hospital and University Hospital Nottingham, has provided a strong foundation in subspecialties like pediatric ophthalmology, endolacrimal, and orbital surgery. He has also worked at Leicester Royal Teaching Hospital as a locum ophthalmologist. In addition to clinical duties, Dr. Eatamadi was the Ophthalmology Residency Program Director (2011–2016) and continues to serve as Associate Program Director. His teaching, audit, and surgical experience have made him a key contributor to the evolution of ophthalmic practice in the UAE and beyond.

🏅 Awards and Honors

Dr. Eatamadi has been recognized for his surgical outcomes, academic leadership, and commitment to excellence in ophthalmology. His internal audits, including the conjunctival ptosis surgery audit at SKMC (2017–2020), achieved a 92% success rate with minimal complications and was subsequently published, reflecting his commitment to clinical quality and evidence-based care. Another notable achievement was his audit on external DCR at Tawam Hospital (2009–2010), where he demonstrated a 95% success rate, aligning with global standards. He is regularly invited to present at international conferences such as the British Oculoplastic Surgery Society and the Emirates Thyroid Congress, where his recent work on thyroid eye disease and biologic treatments has gained regional recognition. As an active member of professional societies including ASOPRS and ITEDS, he contributes to knowledge dissemination and practice improvement. His honors stem from years of clinical excellence, educational mentorship, and innovation in oculoplastic and orbital surgery.

🔬 Research Focus

Dr. Eatamadi’s research interests focus on clinical outcomes and therapeutic advancements in oculoplastics, lacrimal, and orbital surgery. His work integrates surgical precision with modern therapeutic approaches, such as the use of biologics in thyroid eye disease, including Tocilizumab and Teprotumumab, which he presented at leading conferences in 2025. His research extends to outcome-based audits, such as his evaluation of DCR procedures and conjunctival ptosis repairs, reflecting his evidence-based approach to patient care. Additionally, his academic involvement includes curriculum development for ophthalmology residents, promoting research-driven education. Through case audits, clinical trials, and presentations, Dr. Eatamadi continues to shape the future of subspecialty ophthalmology in the UAE. He is particularly interested in enhancing surgical outcomes, reducing complications, and applying new biologics for complex orbital inflammatory conditions. His research focus supports his dual role as a clinician and educator, ensuring that scientific advances are translated into high-quality patient outcomes.

✅ Conclusion

Dr. Habibullah Eatamadi is a highly accomplished oculoplastic surgeon whose international training, extensive experience, academic contributions, and research innovations have significantly advanced ophthalmic care in the UAE and beyond.

Publications

  • Tocilizumab use for optic nerve compression in thyroid eye disease: a prospective longitudinal cohort

  • Eatamadi, H., AlMazrouiel, O., Al Qatan, N., Ibrahim, H., & Eatamadi, S. (2025). Teprotumumab use in Thyroid Eye Disease: Clinical Outcomes in the United Arab Emirates – A First Regional Case Series. Seminars in Ophthalmology. https://doi.org/10.1080/08820538.2025.2503911
  • Habroosh, F. A., Albrashdi, S. S., Alsaadi, A. H., Eatamadi, H. (2024). Tocilizumab Use for Optic Nerve Compression in Thyroid Eye Disease: A Prospective Longitudinal Cohort. International Ophthalmology, 44, 222. https://doi.org/10.1007/s10792-024-03143-4
  • Eatamadi, H., et al. (2024). Economic Burden Impact of Thyroid Eye Disease in the United Arab Emirates. Poster presented at ISPOR USA, May 2024, Atlanta, GA, USA.
  • Alalawi, F., Almazroui, O., Alsaadi, A., Eatamadi, H. (2023). Severe Dysthyroid Optic Neuropathy Following SARS-CoV-2 Vaccination Treated with Tocilizumab: First Two Reported Cases. Open Journal of Clinical & Medical Case Reports, 9(19).
  • Almazrouei, O., Alalawi, F., Albrashdi, S., Alsharqi, H., Alsaadi, A., Hammad, M., Sabri, A., Eatamadi, H. (2023). A 46-Year-Old Woman with a 4-Year History of Graves’ Disease, with Severe Corticosteroid-Unresponsive Thyroid Eye Disease, Successfully Treated with Tocilizumab. American Journal of Case Reports, 24, e938487. https://doi.org/10.12659/AJCR.938487